510(k) Report

510(k) · Cleared

Cleared

Aeye-DS

K221183510(k) TraditionalCleared Nov 10, 2022199-day reviewClass II21 CFR 886.1100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Aeye Health, Inc. · PIB Diabetic Retinopathy Detection Device

Cleared on Nov 10, 2022 as substantially equivalent to DEN180001 (Idx, LLC, 2018) after a 199-day review. Its family tree reaches back 1 generation to 2018. 1 later device descends from it.

Decided
Nov 10, 2022
Review
199 days
Class
Class II
Product code
PIB
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to DEN180001 (2018). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2024: 1 descendant clearedDEN180001 · IDx-DR · Idx, LLC · 2018201620182020202220242026
Descendants, by generation 1 generation forward: 1 descendant DEN180001 · IDx-DR · Idx, LLC · 20180
  1. Root · 1 generation backDEN180001 IDx-DRIdx, LLC · 2018
  2. This deviceK221183 Aeye-DSAeye Health, Inc. · 2022
  3. Descendant · cites it directly · 0 of its ownK240058 Aeye-DSAeye Health, Inc. · 2024

Most influential descendants

Showing 1 of 1 · See all
  • K240058Aeye-DSAeye Health, Inc. · 2024 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN180001IDx-DRIdx, LLC2018—
0 (this device)K221183Aeye-DSAeye Health, Inc.2022—
+1K240058Aeye-DSAeye Health, Inc.2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202410
FIG. 1 — Lineage of K221183, 2018–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PIB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PIB device

  1. #1 K253704 iPredict-DRscore 11.9 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN180001IDx-DR
Summary page 4
…Predicate Device Manufacturer 510(k) No. Main IDx-DR IDx LLC DEN180001 Device Description: AEYE-DS is a retinal diagnostic software device that incorporates an algorithm to evaluate ophthalmic image…
Idx, LLC2018—

Also cleared against DEN180001: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K240058Aeye-DSAeye Health, Inc.20240

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K240058 (Aeye Health, Inc., 2024) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate DEN180001.

How does its category compare?

All PIB devices

PIB Diabetic Retinopathy Detection Device: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · PIB

1in 2024

2018: 12020: 12021: 12022: 22023: 12024: 12026 (partial year): 1
2007high 2 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PIB

Too few PIB 510(k)s in any year since 2007 to give a median.

Recalls per year · PIB

No recall names PIB since 2007.

Adverse event reports per year · PIB

1in 2025

2025: 1
2007high 1 (2025) · low 0 (2007)2025

MAUDE reports naming product code PIB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20181—00
20190—00
20201—00
20211—00
20222—00
20231—00
20241—00
20250—01
20261—0—

What is it indicated for?

The AEYE-DS device is indicated for use by health care providers to automatically detect more than mild diabetic retinopathy (mtmDR) in adults diagnosed with diabetes who have not been previously diagnosed with diabetic retinopathy.

The AEYE-DS is indicated for use with the Topcon NW400.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K221183: Aeye-DS.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K221183

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026